Filing Details
Alkermes plc. (NASDAQ:ALKS) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material event.
8k filedNASDAQ:ALKS
Alkermes plc. (ALKS) Reports Material Event to SEC
Filing Details Alkermes plc. (NASDAQ:ALKS) filed a Form 8-K with the Securities and Exchange Commission on July 08, 2026, disclosing a material event. Market Context Alkermes…
Market Context
Alkermes plc.'s stock currently trades at $54.29 with a market capitalization of $5.0B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Alkermes plc.'s stock.
All SEC filings for Alkermes plc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ALKS Stock Page
Frequently Asked Questions
Where can I read ALKS's SEC filings?
Browse all filings on our ALKS SEC filings page.
What types of SEC filings does Alkermes plc. file?
Public companies like Alkermes plc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.